Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 29, 2017

Primary Completion Date

March 26, 2018

Study Completion Date

March 26, 2018

Conditions

Asthma

Interventions

DRUG

AS MDI

AS MDI 1+1+2+4+8 inhalations of 90 μg per inhalation

DRUG

Proventil

Proventil 1+1+2+4+8 inhalations of 90 μg per inhalation

Trial Locations (5)

Research Site, Raleigh

Research Site, Winter Park

Research Site, St Louis

Research Site, Medford

Research Site, North Dartmouth